NeueHealth, Inc.
NEUE
$6.87
$0.020.29%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 281.17M | 260.93M | 257.73M | 246.32M | 231.97M |
| Total Other Revenue | 626.18M | 675.73M | 739.16M | 787.04M | 873.37M |
| Total Revenue | 907.35M | 936.66M | 996.89M | 1.03B | 1.11B |
| Cost of Revenue | 706.16M | 742.14M | 822.11M | 865.86M | 933.34M |
| Gross Profit | 201.19M | 194.52M | 174.78M | 167.50M | 172.01M |
| SG&A Expenses | 252.57M | 270.66M | 270.56M | 301.44M | 301.49M |
| Depreciation & Amortization | 14.64M | 15.65M | 16.07M | 16.68M | 17.38M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 973.37M | 1.03B | 1.11B | 1.18B | 1.25B |
| Operating Income | -66.02M | -91.79M | -111.86M | -150.62M | -146.85M |
| Income Before Tax | -107.14M | -99.46M | -117.55M | -577.02M | -570.16M |
| Income Tax Expenses | 2.05M | 2.60M | 4.86M | -1.32M | -2.02M |
| Earnings from Continuing Operations | -109.18 | -102.06 | -122.41 | -575.70 | -568.14 |
| Earnings from Discontinued Operations | 2.80M | 2.34M | -440.41M | -493.89M | -532.39M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -24.12M | -34.96M | 201.14M | 131.44M | 108.17M |
| Net Income | -130.51M | -134.68M | -361.67M | -938.16M | -992.36M |
| EBIT | -66.02M | -91.79M | -111.86M | -150.62M | -146.85M |
| EBITDA | -51.38M | -76.14M | -89.92M | -128.07M | -123.61M |
| EPS Basic | -22.00 | -22.63 | -51.16 | -123.67 | -130.72 |
| Normalized Basic EPS | -9.84 | -12.95 | 14.91 | 1.89 | -1.39 |
| EPS Diluted | -22.00 | -22.63 | -51.16 | -123.67 | -130.72 |
| Normalized Diluted EPS | -9.84 | -12.95 | 14.91 | 1.89 | -1.39 |
| Average Basic Shares Outstanding | 33.33M | 32.84M | 32.57M | 32.26M | 31.97M |
| Average Diluted Shares Outstanding | 33.33M | 32.84M | 32.57M | 32.26M | 31.97M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |